Bank of New York Mellon’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
96,415
+28,547
| +42% | +$386K | ﹤0.01% | 2960 |
|
|
2025
Q1 | $1.08M | Buy |
67,868
+2,550
| +4% | +$40.5K | ﹤0.01% | 3010 |
|
|
2024
Q4 | $804K | Buy |
65,318
+1,711
| +3% | +$21.1K | ﹤0.01% | 3261 |
|
|
2024
Q3 | $770K | Sell |
63,607
-21,155
| -25% | -$256K | ﹤0.01% | 3273 |
|
|
2024
Q2 | $992K | Buy |
84,762
+35,634
| +73% | +$417K | ﹤0.01% | 3201 |
|
|
2024
Q1 | $634K | Buy |
49,128
+2,196
| +5% | +$28.4K | ﹤0.01% | 3379 |
|
|
2023
Q4 | $404K | Buy |
46,932
+6,504
| +16% | +$55.9K | ﹤0.01% | 3667 |
|
|
2023
Q3 | $384K | Buy |
40,428
+217
| +0.5% | +$2.06K | ﹤0.01% | 3680 |
|
|
2023
Q2 | $686K | Buy |
40,211
+6,925
| +21% | +$118K | ﹤0.01% | 3419 |
|
|
2023
Q1 | $521K | Buy |
+33,286
| New | +$521K | ﹤0.01% | 3472 |
|